Gene expression analysis of T-ALL cell lines treated with gamma-secretase inhibitor
Ontology highlight
ABSTRACT: Gain-of-function mutations in NOTCH1 are common in T-cell lymphoblastic leukemias making this receptor a promising target for drugs such as gamma-secretase inhibitors (GSI), which block a proteolytic cleavage required for NOTCH1 activation. However, the enthusiasm for these therapies has been tempered by tumor resistance and the paucity of information on the oncogenic programs regulated by oncogenic NOTCH1. Analysis of gene expression in GSI-responsive and GSI-resistant cell lines treated with Compound E identifies differential resopnses to GSI. Keywords: Drug response
ORGANISM(S): Homo sapiens
PROVIDER: GSE5716 | GEO | 2008/08/20
SECONDARY ACCESSION(S): PRJNA97007
REPOSITORIES: GEO
ACCESS DATA